Anti-Psoriatic Effects of Middle Fragment of Chlamydial Plasmid-Encoded Protein pGP3 in an Imiquimod-Induced Psoriasis Mouse Model

Yiming Zhang; Miaomiao Ma; Jun Li; Yingye Wu; Lu Xue; Rongrong Zhao; Lu Wang; Shuping Hou; Huiping Wang

doi:10.12659/MSM.929781

05 June 2021 : Animal Research

Anti-Psoriatic Effects of Middle Fragment of Chlamydial Plasmid-Encoded Protein pGP3 in an Imiquimod-Induced Psoriasis Mouse Model

Yiming Zhang^1A, Miaomiao Ma^2A, Jun Li^3D, Yingye Wu^2C, Lu Xue^2C, Rongrong Zhao^2B, Lu Wang^2E, Shuping Hou^2G, Huiping Wang^2G*

DOI: 10.12659/MSM.929781

Med Sci Monit 2021; 27:e929781

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 6 The cytokines levels in the serum and skin tissue were measured using ELISA. Data are presented as mean±standard deviation (8 mice/group). (A) The levels of IL-17A, IL-22, and IFN-γ in the skin lesions. * P<0.05 compared with the IM-PBS group. (B) The levels of IL-17A, IL-22, and IFN-γ in the serum. * P<0.05 compared with the IM-PBS group.

Back to the Article

Anti-Psoriatic Effects of Middle Fragment of Chlamydial Plasmid-Encoded Protein pGP3 in an Imiquimod-Induced Psoriasis Mouse Model

Your Privacy